Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_provenance.
- NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_assertion description "[KRAS mutations constitutively activate the RAS/RAF/mitogen-activated protein kinase (MAPK) pathway and therefore play an important role in anti-epidermal growth factor receptor therapy for patients with colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_provenance.
- NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_assertion evidence source_evidence_literature NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_provenance.
- NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_assertion SIO_000772 22938585 NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_provenance.
- NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_assertion wasDerivedFrom befree-20140225 NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_provenance.
- NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_assertion wasGeneratedBy ECO_0000203 NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP509861.RAzmFek8mCrAotqmP0MjmhxPZyx_9nxdpSDDN9tbli-CM130_provenance.